USMLE® Step 1 & 2

Kaplan USMLE Step 1: Follow-up for woman with type 2 diabetes

UPDATED . 6 MIN READ

 If you’re preparing for the United States Medical Licensing Examination® (USMLE®) Step 1 exam, you might want to know which questions are most often missed by test-prep takers. Check out this example from Kaplan Medical, and read an expert explanation of the answer. Also check out all posts in this series.

Free study aid when you join the AMA

Medical students who become AMA members can select a free gift from a variety of powerful study aids for the USMLE and COMLEX-USA tests.

Supporting you today as a medical student. Protecting your future as a physician.

A 63-year-old woman with type 2 diabetes mellitus comes to the physician for a follow-up examination. She states that she has attempted diet control and exercise for the last nine months. She has a history of heart failure, hypertension and hypercholesterolemia.

She currently takes enalapril and low-dose aspirin and has no drug allergies. Laboratory studies show a creatinine of 2.2 mg/dL and a hemoglobin A1c of 8.9%.

Which of the following is the most appropriate initial pharmacotherapy for this patient?

A. Glimepiride.

B. Metformin.

C. Metformin and glipizide.

D. Pramlintide.

E. Rosiglitazone.

 

 

 

 

 

 

 

 

 

 

 

 

 

Subscribe and succeed in medical school

Get tips and insider advice from the AMA on succeeding in medical school—delivered to your inbox.

The correct answer is A.

The initial decision about the choice of drug to manage hyperglycemia must take into account the comorbidities of the patient and the relative contraindications of the drug. Insulin secretagogues such as sulfonylureas (glipizide, glyburide, glimepiride), α-glucosidase inhibitors (miglitol, acarbose), thiazolidinediones ("glitazones") (pioglitazone, rosiglitazone), biguanides (metformin), and insulin all are approved for monotherapy for diabetes. 

Most patients are initially started on metformin unless there is a contraindication, such as renal dysfunction (as seen in this patient). Sulfonylureas, DPP-4 inhibitors (sitagliptin), GLP-1 agonists (exenatide) or glitazones (rosiglitazone) are generally used as second line agents when metformin is unsuccessful or cannot be used. In this patient, the most recommended initial treatment would be the sulfonylurea glimepiride.

Choices B and C: Metformin, a biguanide, has a rare but serious complication of lactic acidosis. Despite this risk, it is the drug of choice for type 2 diabetes. A primary reason to use another agent in place of metformin is when the patient is at risk for developing metformin-induced lactic acidosis.

Did you answer the question correctly?

Log in to get tips to remember and learn more from Kaplan Medical about why the other answer choices can be eliminated.

AMA membership has its advantages

  • Access education programs and study guides to help you thrive.
  • Distinguish yourself with AMA leadership opportunities.
  • Enjoy exclusive perks and savings.

Not a member? Become a member now.

FEATURED STORIES FOR MEDICAL STUDENTS